Skip to Content

ZA-35 37.5 mg (Venlafaxine Hydrochloride Extended Release 37.5 mg)

Pill with imprint ZA-35 37.5 mg is Gray & White, Capsule-shape and has been identified as Venlafaxine Hydrochloride Extended Release 37.5 mg. It is supplied by Zydus Pharmaceuticals USA Inc..

Venlafaxine is used in the treatment of anxiety; autism; major depressive disorder; generalized anxiety disorder; depression and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 37.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ZA-35 37.5 mg

Venlafaxine Hydrochloride Extended Release

Imprint
ZA-35 37.5 mg
Strength
37.5 mg
Color
Gray & White
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals USA Inc.
Inactive Ingredients
silicon dioxide, cetostearyl alcohol, gelatin, hypromelloses, microcrystalline cellulose, sodium lauryl sulfate, magnesium silicate, titanium dioxide, ferrosoferric oxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
68382-0034 Zydus Pharmaceuticals (USA) Inc.
60429-0121 Golden State Medical Supply (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.